Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2018 Dec 21;7(5):1580–1588. doi: 10.1016/j.jaip.2018.12.014

Table I.

Patients’ characteristics

AERD patients, N=28
Age (y), mean ±SE 46 ±2.7
Female patients, N (%) 18 (67)
Race, N (%)
African American 14 (50)
Latino 7 (25)
White 7 (25)
ICS/LABA* use, N (%) 23 (82)
Oral corticosteroids use, N (%) 3 (11)
*

ICS/LABA – inhaled corticosteroids/long-acting beta-agonists